Literature DB >> 9703989

Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells.

O N Vidal1, K Sjögren, B I Eriksson, O Ljunggren, C Ohlsson.   

Abstract

Osteoprotegerin (OPG) is a soluble receptor for the Osteoprotegerin-Ligand (OPGL) which is expressed on osteoblasts and mediates the signal for osteoclast differentiation. In the present study we demonstrate that OPG mRNA levels in MG-63 cells are increased in a dose-dependent manner after 8 h of treatment with IL-1 alpha (338 +/- 53% over control at 25 U/ml). Interleukin-6 (IL-6), under similar culture conditions, does not affect OPG mRNA levels. Time-course studies show that IL-1 alpha (25 U/ml) causes a transient increase of OPG mRNA levels in MG-63 cells, peaking after 4 h of treatment. An increase of the OPG transcript occurs in hOB cells at 0.5 h which is still present after 24 h of IL-1 alpha treatment. In MG-63 cells neither basal-nor IL-1 alpha-induced OPG mRNA levels are altered by the translational inhibitor cycloheximide. These results suggest that expression of OPG in osteoblasts may be regulated by IL-1 alpha.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703989     DOI: 10.1006/bbrc.1998.9035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.

Authors:  I Itonaga; A Sabokbar; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

2.  Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5.

Authors:  Agnes Schröder; Patrick Neubert; Jens Titze; Aline Bozec; Wolfgang Neuhofer; Peter Proff; Christian Kirschneck; Jonathan Jantsch
Journal:  JCI Insight       Date:  2019-12-05

Review 3.  Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.

Authors:  Natalia Carrillo-López; Laura Martínez-Arias; Jorge B Cannata-Andía; Manuel Naves-Díaz; Sara Panizo; Sara Fernández-Villabrille; María Piedad Ruiz-Torres; Adriana Dusso
Journal:  Calcif Tissue Int       Date:  2021-02-13       Impact factor: 4.333

4.  Synovial macrophage-osteoclast differentiation in inflammatory arthritis.

Authors:  L Danks; A Sabokbar; R Gundle; N A Athanasou
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

5.  Role of bacterial γ-glutamyltranspeptidase as a novel virulence factor in bone-resorbing pathogenesis.

Authors:  Jinmoon Kim; Sungil Jang; Aeryun Kim; Hanfu Su; Niluka Gunawardhana; Yeong-Eui Jeon; Eun Jung Bak; Ji-Hye Kim; Jeong-Heon Cha
Journal:  J Microbiol       Date:  2016-04-20       Impact factor: 3.422

6.  Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola.

Authors:  Bong-Kyu Choi; Hyun Jung Lee; Jung Hwa Kang; Gook Jin Jeong; Cheon Ki Min; Yun-Jung Yoo
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.

Authors:  H Michael; P L Härkönen; L Kangas; H K Väänänen; T A Hentunen
Journal:  Br J Pharmacol       Date:  2007-04-10       Impact factor: 8.739

Review 8.  Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis.

Authors:  Q Rehman; N E Lane
Journal:  Arthritis Res       Date:  2001-05-18

9.  Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Josep Vergés; Daniel Lajeunesse; Eulàlia Montell; Hassan Fahmi; Martin Lavigne; Johanne Martel-Pelletier
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes.

Authors:  Corinne Granet; Wova Maslinski; Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2004-02-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.